These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29117311)
1. Ketamine Minus the Trip: New Hope for Treatment-Resistant Depression. Abbasi J JAMA; 2017 Nov; 318(20):1964-1966. PubMed ID: 29117311 [No Abstract] [Full Text] [Related]
2. Ketamine for Treatment-Resistant Depression: a New Advocate. Pérez-Esparza R Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013 [TBL] [Abstract][Full Text] [Related]
3. Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches. Limandri BJ J Psychosoc Nurs Ment Health Serv; 2018 Oct; 56(10):11-14. PubMed ID: 30278095 [TBL] [Abstract][Full Text] [Related]
4. Ketamine as an alternative treatment for treatment-resistant depression. Dowben JS; Grant JS; Keltner NL Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991 [No Abstract] [Full Text] [Related]
5. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression. Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388 [No Abstract] [Full Text] [Related]
6. [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression]. Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł Psychiatr Pol; 2012; 46(2):283-94. PubMed ID: 23214398 [TBL] [Abstract][Full Text] [Related]
7. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder. Blier P Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752 [No Abstract] [Full Text] [Related]
8. New use for an old drug: oral ketamine for treatment-resistant depression. Swiatek KM; Jordan K; Coffman J BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27489070 [TBL] [Abstract][Full Text] [Related]
9. NMDA antagonist treatment of depression. Williams NR; Schatzberg AF Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of ketamine. Stahl SM CNS Spectr; 2013 Aug; 18(4):171-4. PubMed ID: 23866089 [TBL] [Abstract][Full Text] [Related]
11. Intravenous ketamine for treatment-resistant major depressive disorder. Covvey JR; Crawford AN; Lowe DK Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250 [TBL] [Abstract][Full Text] [Related]
12. Esketamine nasal spray (Spravato) for treatment-resistant depression. Med Lett Drugs Ther; 2019 Apr; 61(1569):54-57. PubMed ID: 31169797 [No Abstract] [Full Text] [Related]
13. Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective. López-Díaz Á; Murillo-Izquierdo M; Moreno-Mellado E Br J Psychiatry; 2019 Aug; 215(2):447-448. PubMed ID: 31030677 [TBL] [Abstract][Full Text] [Related]